Triple

T6004850
Position Surface form Disambiguated ID Type / Status
Subject C9orf72 E133683 entity
Predicate geneSymbol P68680 FINISHED
Object C9orf72 E133683 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: C9orf72 | Statement: [C9orf72, geneSymbol, C9orf72]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: C9orf72
Context triple: [C9orf72, geneSymbol, C9orf72]
  • A. C9orf72 chosen
    C9orf72 is a human gene whose hexanucleotide repeat expansions are the most common known genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
  • B. SMN2
    SMN2 is a human gene that produces a backup form of survival motor neuron protein and is a key therapeutic target in spinal muscular atrophy.
  • C. SOD1
    SOD1 is a gene encoding the antioxidant enzyme superoxide dismutase 1, whose mutations are a major known cause of familial amyotrophic lateral sclerosis (ALS).
  • D. TARDBP
    TARDBP is a gene encoding the TDP-43 protein, a DNA/RNA-binding protein whose abnormal aggregation is a key pathological feature in amyotrophic lateral sclerosis and related neurodegenerative diseases.
  • E. SMN1 gene
    The SMN1 gene is a human gene whose proper function is critical for motor neuron survival, and mutations in it are the primary cause of spinal muscular atrophy.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: geneSymbol
Context triple: [C9orf72, geneSymbol, C9orf72]
  • A. targetsGene
    Indicates that one entity is directed toward, acts upon, or is intended to affect a specific gene.
  • B. genomeCharacteristic
    Indicates that an entity has a specific property, feature, or attribute related to its genome.
  • C. subunitSymbol
    Indicates that one entity is the symbolic or abbreviated representation (symbol) of a subunit of another entity.
  • D. genomeSource
    Indicates the origin or provenance of a genome, specifying where or how the genomic data was obtained.
  • E. estimatedNumberOfGenes
    Indicates the approximate count of genes that an entity (such as an organism or genome) is believed to possess.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c00872444c8190bfaf1739dcec765c completed March 22, 2026, 3:19 p.m.
NER Named-entity recognition batch_69c04f10d18081908c351170b7f58d3d completed March 22, 2026, 8:20 p.m.
NED1 Entity disambiguation (via context triple) batch_69c11365741c819097a43a49dd2428c1 completed March 23, 2026, 10:18 a.m.
PD Predicate disambiguation batch_69c049e3316c819087ea635fa7ee8472 completed March 22, 2026, 7:58 p.m.
PDg Predicate description generation batch_69c04e8c5bfc8190b986a7071d1b23e3 completed March 22, 2026, 8:18 p.m.
Created at: March 22, 2026, 4:06 p.m.